One man at a time - resolving the PSA controversy - Abstract

Harvard Medical School, 25 Shattuck Street Boston, MA.

Massachusetts General Hospital, 55 Fruit Street, Boston, MA.

 

 

Who should decide about screening for prostate cancer: expert panels of clinicians and methodologists, primary care clinicians, specialists, or fully informed patients themselves? The U.S. Preventive Services Task Force recently released a draft recommendation on screening for prostate cancer, designed for primary care physicians and health systems, and has opened it for public comment until November 8, 2011.(1) After completing a rigorous evidence review, the task force decided to recommend against screening for prostate-specific antigen (PSA), concluding that there is moderate or high certainty that the service has no net benefit or that the harms outweigh the benefits. This grade . . .

Written by:
McNaughton-Collins MF, Barry MJ.   Are you the author?

Reference: N Engl J Med. 2011 Oct 26. Epub ahead of print.
doi: 10.1056/NEJMp1111894

PubMed Abstract
PMID: 22029758

UroToday.com Prostate Cancer Section

 

email news signup